If you want help deciding whether a prescription program is a fit, complete the free assessment quiz to review your next steps
KLOW + GLP-1 microdose therapy
BPC-157 promotes angiogenesis through the Egr-1/NAB2 regulatory loop, which simultaneously activates vessel growth (Egr-1) and provides an internal brake (NAB2) to prevent disorganized growth
In practice, the mild side effect profiles of both peptides make clinically significant additive concerns unlikely
BPC-157, TB-500, KPV, GHK-Cu 80mg (Klow Blend) $395,00 PRODUCT SHORT DESCRIPTION The BPC-157, TB-500, KPV, and GHK-Cu Klow Blend delivers an advanced, multi-pathway 80mg (80,000mcg) research matrix combining four synergistic synthetic peptides in a single vial